Taken together, our findings support the notion that IGF-1R signaling with activation of the downstream PI3K/Akt/mTOR pathway plays an important role in breast cancer progression by controlling both the maintenance of BCSCs and their EMT behavior. The gene discussed is MTOR; the disease is breast carcinoma.